The global market for healthcare-acquired infection treatments is expected to reach more than $30 billion by 2016 at a compound annual growth rate of 9.5 percent, according to a Reportlinker release.
That projection is far higher than the global market valued in 2010 at $16 billion. Markets for infection control devices and products were $8.3 billion in the year 2010 and are expected to reach $10.3 billion by 2011. This market is forecasted to cross $18.3 billion by 2016 at a CAGR of 12 percent.
Additionally, the global market for pharmaceutical treatments is expected to reach $6 billion by 2016 at a 5.8 percent CAGR. The U.S. holds nearly half of the global market for healthcare-association infection products.
Basic Infection Prevention Saved Children's Hospitals $104M Over 5 Yrs
Readmissions in New York Cost $3.7B
That projection is far higher than the global market valued in 2010 at $16 billion. Markets for infection control devices and products were $8.3 billion in the year 2010 and are expected to reach $10.3 billion by 2011. This market is forecasted to cross $18.3 billion by 2016 at a CAGR of 12 percent.
Additionally, the global market for pharmaceutical treatments is expected to reach $6 billion by 2016 at a 5.8 percent CAGR. The U.S. holds nearly half of the global market for healthcare-association infection products.
Related Articles on Healthcare-Acquired Infections:
10 Proven Ways to Reduce Hospital ReadmissionsBasic Infection Prevention Saved Children's Hospitals $104M Over 5 Yrs
Readmissions in New York Cost $3.7B